FTC clears Pfizer/Wyeth with conditions
Wednesday, 14 October 2009
Ron Knox
US drug makers Pfizer and Wyeth have agreed to sell half of Wyeth’s animal health business to end the Federal Trade Commission’s long-running investigation of their US$68 billion merger.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top